Notice No.   20170718-24   Notice Date   18 Jul 2017
Category   Company related   Segment   Equity
Subject   Listing of Equity Shares of Artemis Global Life Science Limited.
Attachments   Annexure A.pdf ;

 Trading Members of the Exchange are hereby informed that effective from Thursday, 20th July, 2017 the equity shares of Artemis Global Life Science Limited shall be listed and admitted to dealings on the Exchange in the list of T Group of Securities. Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012; the scrip will be in Trade-for-Trade segment for 10 trading days.


Members are requested to note that the above security will be a part of special pre-open session for IPO and Other category of scrip’s as per SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012.

For further information on SPOS, the trading members are requested to refer to the Exchange’s notice no. 20120216-29 on Enabling Special Pre-open Session for IPO’s & Relisted Scrips. For any clarification on SPOS, the trading members may please contact the Helpdesk on 022-6136 3100 / 6136 3171.


Name of the Company


Artemis Global Life Science Limited.

Registered Office










414/1 4th Floor,

DDA Commercial Complex

District Centre

Janakpuri, New Delhi 110058.


Tel: +91-11-25617291


Fax: +91-124-4262306


Email ID :

Website :-

Company Secretary & Compliance Officer





Mr. Anuj Sood

Email ID:



64232250 Equity shares of Rs.2/- allotted pursuant to Scheme of Amalgamation

Distinctive numbers


01 to 914694

1068445 to 1068944

1351945 to 1353344

1369645 to 1380094

2870095 to 2873544

2886745 to 66188500

Scrip Code






Market Lot



Face Value & Paid up value


Rs.2/- each fully paid

Scrip ID on BOLT System



Abbreviated name on BOLT



ISIN No.              








            1. The brief particulars of the Scheme of Amalgamation are as mentioned below:

a)    The Scheme of Amalgamation of the Company was approved by the National Company Law Tribunal, Delhi Bench and Hon’ble High Court of Kerala vide its Order dated 01/03/2017 and 08/08/2016 respectively.


b)    Appointed Date: 01/04/2016


c)    Effective date:  08/03/2017


d)    Date of Allotment:  30/03/2017


e)  Pursuant to the Scheme of Arrangement relating to Demerger of Medicare and Health Undertaking of PTL Enterprises Limited into Artemis Global Life Sciences Limited as sanctioned by the Delhi Bench of the Hon’ble National Company Law Tribunal and Hon’ble High Court of Kerala, Artemis Global Life Science Limited has issued to the shareholders of PTL Enterprises Limited, 1 equity share of Rs. 2/- each of Artemis Global Life Science Limited for every 1(ONE) equity Share of Rs. 2/- each held in PTL Enterprises Limited.  The issued, subscribed and paid-up equity capital of the company post amalgamation is Rs. 132377000/-   Equity shares of Rs.2/- consisting of 66188500 Equity shares Rs.2/- each.


2.  As per Exchange Notice No. 20170320-3 dated 20th March 2017, PTL Enterprises Ltd. had fixed Record date as 29/03/2017 for giving effect to the Scheme of   Amalgamation.


3.  The Information Memorandum containing all the information about the company can be viewed at


4.  The name and address of the registrar and share transfer agent of the company is as mentioned below:


Alankit Assignments Limited

Regd Office: 205-208, Anarkali Complex,

Jhandewalan Extension, New Delhi-110055

Corp Office: 1E/13 Alankit Heights Jhandewalan

Extension New Delhi -110 055

Phone: +91-11-42541234 / 23541234/+91-11- 42541201





1.       The shareholding pattern of the company post scheme of arrangement is enclosed as   Annexure A.




Nitin Pujari